New research is suggesting that measuring the pulse wave at a menopausal woman’s wrist may explain the increase in cardiovascular disease risk during menopause better than a standard blood pressure measurement.
New research is suggesting that measuring the pulse wave at a menopausal woman’s wrist may explain the increase in cardiovascular disease risk during menopause better than a standard blood pressure measurement.
Presented at the American Heart Association’s Basic Cardiovascular Sciences 2019 Scientific Sessions, the study found that by using radial pulse waves, measuring the heartbeat through the artery at the base of the wrist can detect circulatory system changes not picked up during blood pressure readings.
“Through mathematical models, we converted the pressure wave of the radial pulse into frequency waves,” Chi-Wei Chang, PhD, director of research and development at the Mii-Ann Medical Research Center in Taipei, Taiwan, and lead author of the study, explained in a statement. “Each frequency wave was assigned a corresponding harmonic amplitude classification from C1 to C5 which provides different information than pulse rate or blood pressure.”
In doing this, the researchers observed that C1, which is related to heart attack, and C3, which is related to heart failure, were impacted. According to Chang, the 2 harmonics in radial pulse waves may shed light on hormonal changes during menopause that indicate the progression of atherosclerosis.
Based on these findings, “Healthcare providers can measure a menopausal woman’s radial pulse to see if the patient’s C1 harmonic is affected. If it is, they can monitor a patient’s situation more closely and take action to prevent cardiovascular disease from becoming more severe,” said Chang. However, he cautioned that more research is needed to confirm this finding and to demonstrate how and why this occurs.
The study included 327 premenopausal and postmenopausal women who had no history of heart disease. Tracking the women’s systolic and diastolic blood pressure measurements, as well as 12-second continuous radial pulse data, the researchers also found that:
Congress Urged to Repeal Comstock Act Threatening Reproductive Rights and Public Health
May 16th 2024In a joint letter addressed to Congress, Healthcare Across Borders, Take Back the Court Action Fund, and UltraViolet Action called out the resurgence of the Comstock Act, urging immediate action to repeal this century-old law that threatens reproductive rights and public health in the US.
Read More
Addressing Maternal Mortality in Medicaid by Focusing on Mental Health
February 15th 2023On this episode of Managed Care Cast, we speak with Inland Empire Health Plan, a managed care plan serving more than 1.4 million residents on Medi-Cal in California, about a new maternal mental health program aimed at supporting new mothers, both before they give birth and afterward.
Listen
Shelly Lanning on How Employers Can Reduce Costs by Bridging Gaps in Women's Health Care
May 3rd 2024In a presentation at the Greater Philadelphia Business Coalition on Health Women’s Health Summit, Shelly Lanning, cofounder and president of Visana Health, addressed the need for comprehensive approaches in women’s health care and their coverage options.
Read More
For National Women’s Health Week, One Company Emphasizes Cardiovascular Risk Management
May 10th 2022On this episode of Managed Care Cast, we speak with Joanne Armstrong, MD, MPH, vice president and chief medical officer for Women’s Health and Genomics at CVS Health, on the distinct pathophysiology of cardiovascular disease in women and how her own health experiences have influenced her perspective on cardiovascular disease management.
Listen
The HHS Office for Civil Rights is investigating whether patient data were exposed in the cyberattack on Change Healthcare; a new study claims that the US’ high maternal mortality rates are the product of flawed data; HHS secretary is open to drug testing recipients of welfare.
Read More